Ozempic to treat addiction, Walgreens closes stores, weight loss drugs for work: Pharma news roundup

May Be Interested In:Yankees Decline Club Option On Veteran Three Time All-Star’s Contract


Graphic: Images: NurPhoto / Contributor, Noom, NurPhoto / Contributor, Spencer Platt

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and intoxications for people with substance use disorders, according to a new study published Thursday in the scientific journal Addiction. Walgreens announced this week that it will close another 1,200 stores in the U.S. over the next three years. And Eli Lilly has partnered with the government of the United Kingdom to see if its blockbuster weight loss drug could help get some people back to work.

Check out those stories and more pharmaceutical news highlights from this week.

share Share facebook pinterest whatsapp x print

Similar Content

jalopnik
20 of the most boring cars ever made
Elon Musk's Tesla robotaxi event is coming. Here's what to know
Elon Musk’s Tesla robotaxi event is coming. Here’s what to know
Tim Walz Says the Electoral College ‘Needs to Go’
Tim Walz Says the Electoral College ‘Needs to Go’
Melania Sheds a Little Light on Trump’s Bedtime Habits
Melania Sheds a Little Light on Trump’s Bedtime Habits
TSMC is making chips for Apple in the U.S.
TSMC is making chips for Apple in the U.S.
Denny Hamlin and Michael Jordan
Denny Hamlin Exposes Michael Jordan’s Fear at 23XI Racing

Leave a Reply

Your email address will not be published. Required fields are marked *

In-Depth Insights: News Beyond the Surface | © 2024 | Daily News